Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-424-3 | CAS number: 95-49-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The LD50 for acute oral toxicity is > 3227 mg/kg bw.
For acute inhalation toxicity a LD50 = 37.5 mg/l (rat, male) was found. In an additional inhalation study male rats and mice were exposed for 1 hour to 20.583 mg/l of the test substance. None of the animals died.
For the endpoint dermal acute toxicity a Waiver is included since reliable oral and inhalation toxicity studies are available. However, a supporting study (RL2, Bayer, 1976) shows that the LD50 is >1.08 g/kg bw (rats, limit dose test). This is supported by two non-reliable studies showing LD50 values above 2000 mg/kg bw/d, the limit for classification.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: in accordance with the guideline
- Principles of method if other than guideline:
- Single oral application by gavage of 1000, 2500, 2750, 3000, 3500, 4000 or 5000/kg bw (male rats) and 500, 1000, 2500, 3000, 4000 or 5000 mg/kg bw (female rats) in 0.5 ml lutrol/100g bw to 15 male and 15 female Wistar rats per dose. Observation period: 14 d, gross pathological examination, calculation of LD50 by Probit analysis.
Study design similar to OECD TG 401. - GLP compliance:
- no
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Vehicle:
- polyethylene glycol
- Doses:
- Male rats: 1000, 2500, 2750, 3000, 3500, 4000 or 5000 mg/kg bw
Female rats: 500, 1000, 2500, 3000, 4000 or 5000 mg/kg bw - No. of animals per sex per dose:
- 15
- Control animals:
- not specified
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 3 227 mg/kg bw
- Mortality:
- See table below
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Single oral application by gavage to male and female Wistar rats resulted in an LD50 (male rats) of 3227 mg/kg bw and an LD50 (female rats) of 3860 mg/kg bw.
- Executive summary:
In a reliable study the substance was applied once by gavage at doses of 1000, 2500, 2750, 3000, 3500, 4000 or 5000/kg bw (male rats) and 500, 1000, 2500, 3000, 4000 or 5000 mg/kg bw (female rats) in 0.5 ml lutrol/100g bw to 15 Wistar rats per sex and dose. The observation period was 14 days. Gross pathological examination was performed and the LD50 was calculated by Probit analysis.
The LD50 (male rats) was 3227 mg/kg bw, the LD50 (female rats) was 3860 mg/kg bw). At at necropsy 14 days post application a reduced size of abdominal organs, especially liver size was found. Mucus membrane of the stomach with focus of inflammation, stomach content appeared to be bloody.
Reference
Mortality:
mg/kg bw | Male | mg/kg bw | Female |
1000 | 0/15 | 500 | 0/15 |
2500 | 0/15 | 1000 | 0/15 |
2750 | 3/15 | 2500 | 0/15 |
3000 | 5/15 | 3000 | 1/15 |
3500 | 10/15 | - | |
4000 | 14/15 | 4000 | 9/15 |
5000 | 15/15 | 5000 | 14/15 |
Mortality (male rats):
up to 2500 mg/kg bw no rat died
from 2750 mg/kg bw onward dose-related increase in mortality (2750 mg/kg bw: 3/15; 5000 mg/kg bw: 15/15)
Signs of intoxication from 2500 mg/kg bw onwards:
poor condition until the 10th day post application and for at least 3 days accompanied by sedation and difficulties in breathing and at higher doses by quasi-narcotic effects.
LD50 (male rats): 3227 (3060-3430) mg/kg bw
Mortality (female rats)
up to 2500 mg/kg bw no rat died
from 3000 mg/kg bw onward dose-related increase in mortality (3000 mg/kg bw: 1/15; 5000 mg/kg bw: 14/15)
Signs of intoxication from 1000 mg/kg bw onwards:
poor condition until the 10th day post application and for at least 3 days accompanied by sedation and difficulties in breathing and at higher doses by quasi-narcotic effects.
LD50 (female rats): 3860 (3542-4198) mg/kg bw
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 3 227 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: well documented and scientifically acceptable
- Principles of method if other than guideline:
- 10 rats were exposed at various nominal concentrations: 3471, 6402, 8406, 8819 ppm to o-chlorotoluene, observation period: 14 d, calculated LC50
- GLP compliance:
- no
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- not specified
- Sex:
- male
- Route of administration:
- inhalation
- Type of inhalation exposure:
- whole body
- Vehicle:
- not specified
- Analytical verification of test atmosphere concentrations:
- not specified
- Duration of exposure:
- 4 h
- Concentrations:
- 3471, 6402, 8406, 8819 ppm = ca. 18.29, 33.73, 44.30, 46.47 mg/l
- No. of animals per sex per dose:
- 10
- Control animals:
- not specified
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- 7 119 ppm
- Exp. duration:
- 4 h
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Ten male rats were exposed whole body to 3471, 6402, 8406, 8819 ppm = ca. 18.29, 33.73, 44.30, 46.47 mg/l for 4 hours. Clinical signs and mortality were recorded during the exposure and a 14 d post observation period. A necropsy was performed. The LC50 value was 7119 ppm (ca. 37.517 mg/l).
- Executive summary:
Ten male rats were exposed whole body to 3471, 6402, 8406, 8819 ppm = ca. 18.29, 33.73, 44.30, 46.47 mg/l for 4 hours. Clinical signs and mortality were recorded during the exposure and a 14 d post observation period. A necropsy was performed. The LC50 value was 7119 ppm (ca. 37.517 mg/l).
Reference
LC50 value: 7119 (6131-8266) ppm = ca. 37.517 mg/l
clinical signs:
during exposure: hypoactivity, dyspnea, abdominal respiration, exudation from eyes and nose, tremors and prostration, duration: 2-4 days at necropsy: uneven coloration on the surface of the lungs and liver and foci of red and black discoloration on the surface of the lungs.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 37.5 mg/m³ air
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: careful observations reported but LD50 value was not reached
- Principles of method if other than guideline:
- 5 rats/sex, hairs removed from the trunk, chemical applied to this prepared area of the skin, single application of 1 ml/kg for 24 hours, during exposure covered with plaster backed with aluminium foil
- GLP compliance:
- no
- Test type:
- other: single dose: 1ml/kg bw for 24 hours
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Duration of exposure:
- 24 hours
- Doses:
- 1 ml/kg bw = 1.08 g/cm³ (density = 1.08 g/cm according LXS MSDS)
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 1 080 mg/kg bw
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- To 5 rats/sex the hairs was removed from the trunk and the chemical applied to this prepared area of the skin. During the single application of 1 ml/kg for 24 hours, the skin was covered with plaster backed with aluminium foil.
Result: LD50 > 1.08 g/kg bw (rat); no death occured - Executive summary:
The chemical was applied to five rats per sex (hairs removed from the trunk). During the single application of 1 ml/kg for 24 hours, the skin was covered with plaster backed with aluminium foil.
Result: LD50 > 1.08 g/kg bw (rat); no death occured. Immediately after application the animals showed excitation for 2 hours, within 24 h difficulty of breathing occured. The general condition of the animals was reduced up to 8 d after administration of the test substance.
Referenceopen allclose all
Immediately after the application, the animals showed excitation obviously induced by pain and lasting for up to 2 h, within 24 h difficulty of breathing occurred; the general condition of the animals was reduced up to 8 d after administration of the test substance; no deaths occurred; after 24 h, the treated areas of skin showed no signs of irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 1.08 mg/kg bw
Additional information
In a reliable acute oral toxicity study (RL 2, similar to OECD TG 401) the substance was applied once by gavage at doses of 1000, 2500, 2750, 3000, 3500, 4000 or 5000/kg bw (male rats) and 500, 1000, 2500, 3000, 4000 or 5000 mg/kg bw (female rats) in 0.5 ml lutrol/100g bw to 15 Wistar rats per sex and dose. The observation period was 14 days. Gross pathological examination was performed and the LD50 was calculated by Probit analysis. The LD50 (male rats) was 3227 mg/kg bw, the LD50 (female rats) was 3860 mg/kg bw. At necropsy 14 days post application a reduced size of abdominal organs, especially liver size was found. Mucus membrane of the stomach with focus of inflammation, stomach content appeared to be bloody. The result is supported by acute oral toxicity studies in several species (rat, mouse, cat and dog). Non of these studies is rated as reliable, however, taken together, the results support the findings in the key study.
In a reliable acute inhalation study (RL 2, well documented and scientifically acceptable) rats were exposed to 4 different concentrations to vapour of o-chlorotoluene for 4 hours. A LC50 of 7119 ppm (ca. 37.517 mg/l) for male rats was found. A further valid study on rats and mice was conducted. In both species no death occurred when exposed to 20.583 mg/l air for 1 hour.
In a reliable acute dermal toxicity study which has some limitations rats received a single application of 1 ml/kg bw (highest applied dose) for 24 hours. During exposure the application was covered with plaster backed with aluminium foil. The LD50 was > 1.08 mg/kg bw (rat, limit test).
For the endpoint dermal acute toxicity a Waiver is included since reliable oral and inhalation toxicity studies are available and the reliable acute dermal toxicity studies did not test up to the concentration relevant for classification (2000 mg/kg bw). However, as outlied above, the limit test showed an LD50 >1.08 g/kg bw, supported by two not assignable studies (secondary literature) on rabbits with LD 50 > 2165 mg/kg bw and LD50 > 7940 mg/kg bw.
Justification for classification or non-classification
Due to the results of the acute oral and dermal toxicity studies a classification according to EU Regulation 1272/2008 (CLP) is not justified.
According to EU Regulation 1272/2008 (CLP), Table 3.1 2-chlorotoluene has a harmonised classificatiuon and is classified for Acute Tox. 4 (inhalation), H 332. Despite the fact that based on the acute inhalation toxicity studies reported here , no classification according to EU Regulation 1272/2008 is warranred, the classification of the test substance for Acute Tox. 4 (inhalation), H 332 will be adopted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.